Insights

Gathering insights about Ginkgo…

Similar companies to Ginkgo

Ginkgo Tech Stack

Ginkgo uses 8 technology products and services including Zendesk, jQuery, Amazon ALB, and more. Explore Ginkgo's tech stack below.

Zendesk
Documentation Tools
jQuery
Javascript Libraries
Amazon ALB
Load Balancers
Ruby
Programming Languages
HSTS
Security
HTTP/3
Web & Portal Technology
X-Content-Type-Options
Web & Portal Technology
Ruby on Rails
Web Frameworks

Media & News

Acurx Pharmaceuticals Announces Presentation of Results from Leiden University Medical Center Public-Private Partnership for Its DNA pol IIIC Inhibitors at the Federation of American Societies for Experimental Biology Scientific Conference
Results are from Acurx's ongoing scientific collaboration with Leiden University Medical Center (LUMC) partially under a grant from Health Holland to further study the mechanism of action of DNA pol IIIC inhibitors LUMC highlighted Acurx's new class of promising antimicrobials, ibezapolstat and related analogues Novel chemotype specifically targeting gram-positive bacteria through an unexploited target Ibezapolstat ready to enter pivotal Phase 3 clinical trials for C. difficile Infection (CDI), with no cross resistance reported to date Ibezapolstat has previously been granted FDA QIDP and Fast-Track Designations and has received SME (Small and Medium-sized Enterprise) designation by the EMA STATEN ISLAND, N.Y.
Jun 09, 2025 | www.prnewswire.com
Telomir Pharmaceuticals Announces Telomir-1 Resets the Body's Epigenetic Clock, Reverses DNA Methylation, and Restores Youthful Gene Regulation in an Ultra-Rare Accelerated Aging Animal Model of Werner Syndrome
Treatment restored gene control, extended telomere length beyond healthy levels, reversed muscle and weight loss, reduced oxidative stress, and resulted in 100% survival - highlighting Telomir-1's potential to reverse key hallmarks of aging MIAMI, FL / ACCESS Newswire / June 5, 2025 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or the "Company," an emerging leader in age-reversal science, today announced compelling new preclinical data demonstrating that its lead candidate, Telomir-1, administered orally, significantly increases telomere length, reverses body weight and muscle loss, and resets cellular aging markers in a validated animal model of Werner Syndrome (WS)-a rare genetic disorder also known as adult-onset progeria. These findings confirm and build upon the Company's previously reported results from a preclinical C.
Jun 05, 2025 | www.accessnewswire.com
Applied DNA Announces 1-For-15 Reverse Stock Split Effective June 2, 2025
STONY BROOK, NY / ACCESS Newswire / May 29, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced that it will effect a 1-for-15 reverse stock split of its issued and outstanding common stock. The Reverse Stock Split will become effective at 12:01 a.m.
May 29, 2025 | www.accessnewswire.com
Telesis Bio Announces Licensing Agreement with Regeneron to Adopt Gibson SOLA™ Platform for Rapid On-Site DNA and Gene Synthesis
SAN DIEGO--(BUSINESS WIRE)--Telesis Bio Inc. (OTCMKTS: TBIO), a leading provider of DNA and mRNA synthesis solutions to accelerate therapeutic discovery with fast and flexible on-site automated foundries, today announced a new license agreement with Regeneron Pharmaceuticals, Inc. to deploy Telesis Bio's revolutionary Gibson SOLA™ platform at its R&D core facilities. This will help Regeneron adopt automated, high-throughput, on-demand gene synthesis in their own labs. Using Gibson SOLA at s.
May 28, 2025 | www.businesswire.com
Ginkgo Bioworks Announces Appointment of Steven Coen as Chief Financial Officer
BOSTON , May 21, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA, "Ginkgo" or the "Company"), which is building the leading platform for cell programming and biosecurity, today announced that Mark Dmytruk, the Company's Chief Financial Officer, intends to resign from his role at the Company on May 30, 2025 to accept a position at another organization and Steven Coen, CPA, the Company's Chief Accounting Officer, will become Chief Financial Officer, effective upon Mr. Dmytruk's resignation.
May 21, 2025 | www.prnewswire.com
23andMe was once worth $6 billion. What's left of the DNA testing startup is being bought for $256 million.
Regeneron Pharmaceuticals will acquire 23andMe's assets for $256 million, both companies said. 23andMe filed for Chapter 11 bankruptcy earlier this year.
May 19, 2025 | www.businessinsider.com
23andMe sells its most valuable asset. Regeneron promises keep your DNA private.
Regeneron said it will continue uninterrupted service of 23andMe's consumer genome services — such as connecting with living relatives with shared DNA — after its purchase closes as expected in the third quarter of this year.
May 19, 2025 | www.marketwatch.com

Ginkgo's Email Address Formats

Ginkgo uses at least 2 format(s):

Ginkgo Email Formats	Example	Percentage
First.Last@citiesense.com	John.Doe@citiesense.com	67%
First@citiesense.com	John@citiesense.com	33%

Frequently Asked Questions

Where is Ginkgo's headquarters located?

Ginkgo's main headquarters is located at 335 Madison Ave, 4th Floor New York, NY 10017, US. The company has employees across 3 continents, including North AmericaAfricaEurope.

What is Ginkgo's phone number?

You can contact Ginkgo's main corporate office by phone at

+1-203-946-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Ginkgo's stock symbol?

Ginkgo is a publicly traded company; the company's stock symbol is DNA.

What is Ginkgo's official website and social media links?

Ginkgo's official website is ginkgo.city and has social profiles on LinkedIn Crunchbase.

How much revenue does Ginkgo generate?

As of June 2025, Ginkgo's annual revenue reached $750K.

What is Ginkgo's NAICS code?

Ginkgo's NAICS code is 518 - Data Processing, Hosting, and Related Services.

How many employees does Ginkgo have currently?

As of June 2025, Ginkgo has approximately 7 employees across 3 continents, including North AmericaAfricaEurope. Key team members include Head Of Business Development & Policy: E. S.Head Of Customer Success: M. W.Co-Founder, Ceo & Head Of Product: S. C.. Explore Ginkgo's employee directory with LeadIQ.

What industry does Ginkgo belong to?

Ginkgo operates in the Data Infrastructure and Analytics industry.

What technology does Ginkgo use?

Ginkgo's tech stack includes ZendeskjQueryAmazon ALBRubyHSTSHTTP/3X-Content-Type-OptionsRuby on Rails.

What is Ginkgo's email format?

Ginkgo's email format typically follows the pattern of . Find more Ginkgo email formats with LeadIQ.

How much funding has Ginkgo raised to date?

As of June 2025, Ginkgo has raised $60K in funding. The last funding round occurred on Mar 02, 2017 for $60K.

When was Ginkgo founded?

Ginkgo was founded in 2015.

Ginkgo

Data Infrastructure and AnalyticsUnited States2-10 Employees

Your go-to technology partner to solve your community’s data management and mapping needs. Ginkgo takes a community-first approach to helping cities. We equip local organizations like Business Improvement Districts and small business groups with record keeping and location intelligence tools to manage and track their impact as they build resilient and thriving mixed-use neighborhoods.

Company Overview

Headquarters: 335 Madison Ave, 4th Floor New York, NY 10017, US
Phone number: +1-203-946-****
Website: ginkgo.city
Stock Symbol: DNA
NAICS Code: 518 - Data Processing, Hosting, and Related Services
Founded: 2015
Employees: 2-10

Media & News

Funding & Financials

$60K
Ginkgo has raised a total of $60K of funding over 1 rounds. Their latest funding round was raised on Mar 02, 2017 in the amount of $60K.
$10M
Ginkgo's revenue is in the range of $10M

Funding & Financials

$60K
Ginkgo has raised a total of $60K of funding over 1 rounds. Their latest funding round was raised on Mar 02, 2017 in the amount of $60K.
$10M
Ginkgo's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Ginkgo

UrbanFootprint

Cityzenith

Bentley Systems

ESRI

Mapbox

Autodesk

HERE Technologies

Nearmap

Ginkgo Tech Stack

Media & News

Acurx Pharmaceuticals Announces Presentation of Results from Leiden University Medical Center Public-Private Partnership for Its DNA pol IIIC Inhibitors at the Federation of American Societies for Experimental Biology Scientific Conference

Telomir Pharmaceuticals Announces Telomir-1 Resets the Body's Epigenetic Clock, Reverses DNA Methylation, and Restores Youthful Gene Regulation in an Ultra-Rare Accelerated Aging Animal Model of Werner Syndrome

Applied DNA Announces 1-For-15 Reverse Stock Split Effective June 2, 2025

Telesis Bio Announces Licensing Agreement with Regeneron to Adopt Gibson SOLA™ Platform for Rapid On-Site DNA and Gene Synthesis

Ginkgo Bioworks Announces Appointment of Steven Coen as Chief Financial Officer

23andMe was once worth $6 billion. What's left of the DNA testing startup is being bought for $256 million.

23andMe sells its most valuable asset. Regeneron promises keep your DNA private.

Ginkgo's Email Address Formats

Frequently Asked Questions

Where is Ginkgo's headquarters located?

What is Ginkgo's phone number?

What is Ginkgo's stock symbol?

What is Ginkgo's official website and social media links?

How much revenue does Ginkgo generate?

What is Ginkgo's NAICS code?

How many employees does Ginkgo have currently?

What industry does Ginkgo belong to?

What technology does Ginkgo use?

What is Ginkgo's email format?

How much funding has Ginkgo raised to date?

When was Ginkgo founded?

Ginkgo

Company Overview

Media & News

Acurx Pharmaceuticals Announces Presentation of Results from Leiden University Medical Center Public-Private Partnership for Its DNA pol IIIC Inhibitors at the Federation of American Societies for Experimental Biology Scientific Conference

Telomir Pharmaceuticals Announces Telomir-1 Resets the Body's Epigenetic Clock, Reverses DNA Methylation, and Restores Youthful Gene Regulation in an Ultra-Rare Accelerated Aging Animal Model of Werner Syndrome

Applied DNA Announces 1-For-15 Reverse Stock Split Effective June 2, 2025

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?